BillionToOne, Inc. Chairman and CEO Oguzhan Atay filed a Form 4 on October 30, 2026, reporting stock option exercises and share sales of Class A Common Stock executed on October 28, 2026, under pre-established Rule 10b5-1 trading plans.
Director Steven R. Gardner filed a Form 4 with the SEC on October 30, 2026, reporting the sale of 10,522 shares of Columbia Banking System, Inc. common stock on October 29, 2026, across seven separate transactions.
Robert Dennehy, Senior VP and COO of MACOM Technology Solutions Holdings, Inc., filed a Form 4 on October 30, 2026, reporting the disposition of 241 shares of common stock on October 28, 2026, to cover tax withholding obligations tied to a restricted stock unit …
MACOM Technology Solutions Holdings SVP of Global Sales Hwang Donghyun Thomas filed a Form 4 on October 30, 2026, disclosing the withholding of 229 shares of common stock on October 28, 2026, to cover tax obligations tied to the vesting of restricted stock units.
ACPS P.G. Trust filed a Form 4 with the SEC on October 30, 2026, disclosing the sale of a combined 30,000 shares of Hyatt Hotels Corp Class B Common Stock on October 29, 2026, with the shares converting to Class A Common Stock upon …
A Form 4 filed on October 30, 2026, reports that Settlement T-551-7, a reporting person associated with Hyatt Hotels Corp (NYSE:H), disposed of 87,694 shares of Class B Common Stock on October 29, 2026, with those shares converting into Class A Common Stock upon …
Frank Keller, President of Checkout Solutions and PayPal at PayPal Holdings, Inc., filed a Form 4 on October 30, 2026, disclosing the sale of 732 shares of PayPal common stock on October 28, 2026, pursuant to a Rule 10b5-1 plan.
Ambra R. Roth, SVP, General Counsel and Secretary of MACOM Technology Solutions Holdings, Inc. (NASDAQ:MTSI), filed a Form 4 on October 30, 2026, disclosing that 279 shares of common stock were withheld by the issuer on October 28, 2026, to satisfy tax withholding obligations …
Galaxy Gaming, Inc. CEO and President Matthew David Reback filed a Form 4 on October 30, 2026, disclosing the acquisition of 100,000 shares of common stock on August 20, 2026.
Giles Richard Platford, President of Takeda Pharmaceutical Co. Ltd.'s International Business Unit, filed a Form 144 notice on October 30, 2026, proposing the sale of 55,617 American Depositary Shares of Takeda Pharmaceutical Co. Ltd. on or around November 1, 2026.